Gastrointestinal stromal tumors, version 2.2014: Featured updates to the NCCN Guidelines

Margaret Von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ephraim S. Casper, Ernest U. Conrad, Thomas F. DeLaney, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Joel Mayerson, Sean V McGarry, Christian Meyer, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, John D. PfeiferRichard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, Brian A. Van Tine, Jeffrey D. Wayne, Mary Anne Bergman, Hema Sundar

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights high-light the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.

Original languageEnglish (US)
Pages (from-to)853-862
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2014

Fingerprint

Gastrointestinal Stromal Tumors
Sarcoma
Guidelines
Platelet-Derived Growth Factor Receptors
Disease Progression
Gastrointestinal Tract
Light
Mutation
Imatinib Mesylate
sunitinib

ASJC Scopus subject areas

  • Oncology

Cite this

Von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Casper, E. S., ... Sundar, H. (2014). Gastrointestinal stromal tumors, version 2.2014: Featured updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 12(6), 853-862. https://doi.org/10.6004/jnccn.2014.0080

Gastrointestinal stromal tumors, version 2.2014 : Featured updates to the NCCN Guidelines. / Von Mehren, Margaret; Randall, R. Lor; Benjamin, Robert S.; Boles, Sarah; Bui, Marilyn M.; Casper, Ephraim S.; Conrad, Ernest U.; DeLaney, Thomas F.; Ganjoo, Kristen N.; George, Suzanne; Gonzalez, Ricardo J.; Heslin, Martin J.; Kane, John M.; Mayerson, Joel; McGarry, Sean V; Meyer, Christian; O'Donnell, Richard J.; Pappo, Alberto S.; Paz, I. Benjamin; Pfeifer, John D.; Riedel, Richard F.; Schuetze, Scott; Schupak, Karen D.; Schwartz, Herbert S.; Van Tine, Brian A.; Wayne, Jeffrey D.; Bergman, Mary Anne; Sundar, Hema.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 6, 01.06.2014, p. 853-862.

Research output: Contribution to journalArticle

Von Mehren, M, Randall, RL, Benjamin, RS, Boles, S, Bui, MM, Casper, ES, Conrad, EU, DeLaney, TF, Ganjoo, KN, George, S, Gonzalez, RJ, Heslin, MJ, Kane, JM, Mayerson, J, McGarry, SV, Meyer, C, O'Donnell, RJ, Pappo, AS, Paz, IB, Pfeifer, JD, Riedel, RF, Schuetze, S, Schupak, KD, Schwartz, HS, Van Tine, BA, Wayne, JD, Bergman, MA & Sundar, H 2014, 'Gastrointestinal stromal tumors, version 2.2014: Featured updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 6, pp. 853-862. https://doi.org/10.6004/jnccn.2014.0080
Von Mehren, Margaret ; Randall, R. Lor ; Benjamin, Robert S. ; Boles, Sarah ; Bui, Marilyn M. ; Casper, Ephraim S. ; Conrad, Ernest U. ; DeLaney, Thomas F. ; Ganjoo, Kristen N. ; George, Suzanne ; Gonzalez, Ricardo J. ; Heslin, Martin J. ; Kane, John M. ; Mayerson, Joel ; McGarry, Sean V ; Meyer, Christian ; O'Donnell, Richard J. ; Pappo, Alberto S. ; Paz, I. Benjamin ; Pfeifer, John D. ; Riedel, Richard F. ; Schuetze, Scott ; Schupak, Karen D. ; Schwartz, Herbert S. ; Van Tine, Brian A. ; Wayne, Jeffrey D. ; Bergman, Mary Anne ; Sundar, Hema. / Gastrointestinal stromal tumors, version 2.2014 : Featured updates to the NCCN Guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2014 ; Vol. 12, No. 6. pp. 853-862.
@article{2b453a76f4e3470b8ef672ce6eacdaa9,
title = "Gastrointestinal stromal tumors, version 2.2014: Featured updates to the NCCN Guidelines",
abstract = "Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights high-light the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.",
author = "{Von Mehren}, Margaret and Randall, {R. Lor} and Benjamin, {Robert S.} and Sarah Boles and Bui, {Marilyn M.} and Casper, {Ephraim S.} and Conrad, {Ernest U.} and DeLaney, {Thomas F.} and Ganjoo, {Kristen N.} and Suzanne George and Gonzalez, {Ricardo J.} and Heslin, {Martin J.} and Kane, {John M.} and Joel Mayerson and McGarry, {Sean V} and Christian Meyer and O'Donnell, {Richard J.} and Pappo, {Alberto S.} and Paz, {I. Benjamin} and Pfeifer, {John D.} and Riedel, {Richard F.} and Scott Schuetze and Schupak, {Karen D.} and Schwartz, {Herbert S.} and {Van Tine}, {Brian A.} and Wayne, {Jeffrey D.} and Bergman, {Mary Anne} and Hema Sundar",
year = "2014",
month = "6",
day = "1",
doi = "10.6004/jnccn.2014.0080",
language = "English (US)",
volume = "12",
pages = "853--862",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Gastrointestinal stromal tumors, version 2.2014

T2 - Featured updates to the NCCN Guidelines

AU - Von Mehren, Margaret

AU - Randall, R. Lor

AU - Benjamin, Robert S.

AU - Boles, Sarah

AU - Bui, Marilyn M.

AU - Casper, Ephraim S.

AU - Conrad, Ernest U.

AU - DeLaney, Thomas F.

AU - Ganjoo, Kristen N.

AU - George, Suzanne

AU - Gonzalez, Ricardo J.

AU - Heslin, Martin J.

AU - Kane, John M.

AU - Mayerson, Joel

AU - McGarry, Sean V

AU - Meyer, Christian

AU - O'Donnell, Richard J.

AU - Pappo, Alberto S.

AU - Paz, I. Benjamin

AU - Pfeifer, John D.

AU - Riedel, Richard F.

AU - Schuetze, Scott

AU - Schupak, Karen D.

AU - Schwartz, Herbert S.

AU - Van Tine, Brian A.

AU - Wayne, Jeffrey D.

AU - Bergman, Mary Anne

AU - Sundar, Hema

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights high-light the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.

AB - Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights high-light the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.

UR - http://www.scopus.com/inward/record.url?scp=84902515659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902515659&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0080

DO - 10.6004/jnccn.2014.0080

M3 - Article

C2 - 24925196

AN - SCOPUS:84902515659

VL - 12

SP - 853

EP - 862

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -